Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 22 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Les Pharmaciens Associés from Anderlecht, company number BE0898893060, closed financial year 2025 with a result of € -637,526 after tax. For that financial year Les Pharmaciens Associés recorded revenue of € 16.9 million and equity of € -4.7 million. Compared with financial year 2024, the result moved from € -293,714 to € -637,526. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.
€ -4.7 million
▼ € 637,526 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -637,526
▼ 117 % more loss than in 2024
Profit after tax over the fiscal year.
€ 134,436
▲ 137% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -4.9 million.
People and assets in 2025
17.6
Average over the fiscal year, from the social balance sheet.
€ 1.2 million
▲ 7% vs 2024
€ 67,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 620
▼ 23% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.8 million
▲ 36% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 38 days on average.
€ 122,094
▼ 10% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 15,408,722 | € 17,316,969 | € 17,482,380 | € 16,939,066 | ▼ 3% |
| Profit after taxes | € -401,195 | € -425,350 | € -293,714 | € -637,526 | ▼ € 343,811 |
| Equity | € -3,362,899 | € -3,788,249 | € -4,081,964 | € -4,719,489 | ▼ € 637,526 |
| Total debts | € 8,744,014 | € 9,027,174 | € 8,776,868 | € 9,522,359 | ▲ 8% |
| Cash | € 132,813 | € 76,502 | € 56,807 | € 134,436 | ▲ 137% |
| Retained profit | € -3,512,899 | € -3,938,249 | € -4,231,964 | € -4,869,489 | ▼ € 637,526 |
| Balance sheet total | € 5,381,115 | € 5,238,924 | € 4,694,905 | € 4,802,870 | ▲ 2% |
| Employees (FTE) | 16.7 | 17.3 | 17.6 | 17.6 |
Key figures of Les Pharmaciens Associés, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Les Pharmaciens Associés?
What happened at Les Pharmaciens Associés in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- SOBEDIP SA stepped down as director. NBB
- PAUL RANSART stepped down as director. NBB
- OLIVIER BRONCHAIN stepped down as director. NBB
- ANNE VALETTE stepped down as director. NBB
- BERTRAND BUSSY stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 637,526. Source: NBB ↗
- SOBEDIP SA became a director. NBB
- PAUL RANSART became a director. NBB
In short
From € 401,195 loss in 2022 to € 637,526 loss in 2025.
Paid € 6,243 in corporate taxes since 2022.
Pays suppliers within 38 days on average.
A new publication or filing at Les Pharmaciens Associés? We notify you, reason included.
Follow Les Pharmaciens AssociésDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by SOBEDIP (99.8%) and DIVERS (0.2%).
Directors
According to the 2025 annual accounts
ANNE VALETTE
Director
since 2022 · until 2028
since 2023 · until 2029
Director · represented by ARMAND PINTON
Also active at: CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE
since 2024 · until 2030
since 2022 · until 2028
PAUL RANSART
Director
Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS, IMMOLENANS, APOGREZ, ANCIAUX, LES PHARMACIES RURALES +15 more
since 2024 · until 2030
Shareholders
99.8%
DIVERS
0.2%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Humaniteitslaan 55
1070 Anderlecht
Middelweg 90 box Bât. B
1130 Brussel
Active since 18 June 2008
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0898.893.060
- VAT number
- BE 0898.893.060
- Registered office
- Humaniteitslaan 55, 1070 Anderlecht
- Names & denominations
- Les Pharmaciens Associés
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 June 2008
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Detailhandel in farmaceutische producten